Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 215

1.

Intact global cognitive and olfactory ability predicts lack of transition to dementia.

Devanand DP, Lee S, Luchsinger JA, Andrews H, Goldberg T, Huey ED, Schupf N, Manly J, Stern Y, Kreisl WC, Mayeux R.

Alzheimers Dement. 2019 Oct 23. pii: S1552-5260(19)35374-9. doi: 10.1016/j.jalz.2019.08.200. [Epub ahead of print]

PMID:
31676234
2.

Escitalopram for agitation in Alzheimer's disease (S-CitAD): Methods and design of an investigator-initiated, randomized, controlled, multicenter clinical trial.

Ehrhardt S, Porsteinsson AP, Munro CA, Rosenberg PB, Pollock BG, Devanand DP, Mintzer J, Rajji TK, Ismail Z, Schneider LS, Baksh SN, Drye LT, Avramopoulos D, Shade DM, Lyketsos CG; S-CitAD Research Group.

Alzheimers Dement. 2019 Nov;15(11):1427-1436. doi: 10.1016/j.jalz.2019.06.4946. Epub 2019 Oct 3.

PMID:
31587995
3.

Long-Term Test-Retest Reliability of the UPSIT in Cognitively Intact Older Adults.

Devanand DP, Liu X, Cohen H, Budrow J, Schupf N, Manly J, Lee S.

Chem Senses. 2019 Jul 17;44(6):365-369. doi: 10.1093/chemse/bjz025.

PMID:
31111142
4.

Role of Amyloid-β and Tau Proteins in Alzheimer's Disease: Confuting the Amyloid Cascade.

Gulisano W, Maugeri D, Baltrons MA, Fà M, Amato A, Palmeri A, D'Adamio L, Grassi C, Devanand DP, Honig LS, Puzzo D, Arancio O.

J Alzheimers Dis. 2019;68(1):415. doi: 10.3233/JAD-189015. No abstract available.

PMID:
30883364
5.

Advancing Research on Care Needs and Supportive Approaches for Persons With Dementia: Recommendations and Rationale.

Kolanowski A, Fortinsky RH, Calkins M, Devanand DP, Gould E, Heller T, Hodgson NA, Kales HC, Kaye J, Lyketsos C, Resnick B, Schicker M, Zimmerman S.

J Am Med Dir Assoc. 2018 Dec;19(12):1047-1053. doi: 10.1016/j.jamda.2018.07.005. Epub 2018 Aug 23.

6.

Donepezil Treatment in Patients With Depression and Cognitive Impairment on Stable Antidepressant Treatment: A Randomized Controlled Trial.

Devanand DP, Pelton GH, D'Antonio K, Ciarleglio A, Scodes J, Andrews H, Lunsford J, Beyer JL, Petrella JR, Sneed J, Ciovacco M, Doraiswamy PM.

Am J Geriatr Psychiatry. 2018 Oct;26(10):1050-1060. doi: 10.1016/j.jagp.2018.05.008. Epub 2018 Jun 28.

7.

Clinical and radiological characteristics of early versus late mild cognitive impairment in patients with comorbid depressive disorder.

Motter JN, Pelton GH, D'Antonio K, Rushia SN, Pimontel MA, Petrella JR, Garcon E, Ciovacco MW, Sneed JR, Doraiswamy PM, Devanand DP.

Int J Geriatr Psychiatry. 2018 Dec;33(12):1604-1612. doi: 10.1002/gps.4955. Epub 2018 Jul 23.

8.

Viral Hypothesis and Antiviral Treatment in Alzheimer's Disease.

Devanand DP.

Curr Neurol Neurosci Rep. 2018 Jul 14;18(9):55. doi: 10.1007/s11910-018-0863-1. Review.

9.

Sex Differences in the Neuropsychiatric Symptoms of Patients With Alzheimer's Disease.

Tao Y, Peters ME, Drye LT, Devanand DP, Mintzer JE, Pollock BG, Porsteinsson AP, Rosenberg PB, Schneider LS, Shade DM, Weintraub D, Yesavage J, Lyketsos CG, Munro CA.

Am J Alzheimers Dis Other Demen. 2018 Nov;33(7):450-457. doi: 10.1177/1533317518783278. Epub 2018 Jul 3.

10.

Role of Amyloid-β and Tau Proteins in Alzheimer's Disease: Confuting the Amyloid Cascade.

Gulisano W, Maugeri D, Baltrons MA, Fà M, Amato A, Palmeri A, D'Adamio L, Grassi C, Devanand DP, Honig LS, Puzzo D, Arancio O.

J Alzheimers Dis. 2018;64(s1):S611-S631. doi: 10.3233/JAD-179935. Review.

PMID:
29865055
11.

Lithium Treatment for Agitation in Alzheimer's disease (Lit-AD): Clinical rationale and study design.

Devanand DP, Strickler JG, Huey ED, Crocco E, Forester BP, Husain MM, Vahia IV, Andrews H, Wall MM, Pelton GH.

Contemp Clin Trials. 2018 Aug;71:33-39. doi: 10.1016/j.cct.2018.05.019. Epub 2018 May 31.

12.

Impaired Identification of Specific Odors and Cognition in Older Adults.

Devanand DP.

Am J Geriatr Psychiatry. 2018 Aug;26(8):847-848. doi: 10.1016/j.jagp.2018.03.009. Epub 2018 Mar 27. No abstract available.

PMID:
29704987
13.

Odor Identification Ability Predicts PET Amyloid Status and Memory Decline in Older Adults.

Kreisl WC, Jin P, Lee S, Dayan ER, Vallabhajosula S, Pelton G, Luchsinger JA, Pradhaban G, Devanand DP.

J Alzheimers Dis. 2018;62(4):1759-1766. doi: 10.3233/JAD-170960.

14.

Change in Odor Identification Impairment is Associated with Improvement with Cholinesterase Inhibitor Treatment in Mild Cognitive Impairment.

Devanand DP, Lentz C, Chunga RE, Ciarleglio A, Scodes JM, Andrews H, Schofield PW, Stern Y, Huey ED, Bell K, Pelton GH.

J Alzheimers Dis. 2017;60(4):1525-1531. doi: 10.3233/JAD-170497.

PMID:
29081417
15.

Relation of Odor Identification with Alzheimer's Disease Markers in Cerebrospinal Fluid and Cognition.

Reijs BLR, Ramakers IHGB, Elias-Sonnenschein L, Teunissen CE, Koel-Simmelink M, Tsolaki M, Wahlund LO, Waldemar G, Hausner L, Johannsen P, Vanderstichele H, Verhey F, Devanand DP, Visser PJ.

J Alzheimers Dis. 2017;60(3):1025-1034. doi: 10.3233/JAD-170564.

PMID:
28984603
16.

Utility of Molecular and Structural Brain Imaging to Predict Progression from Mild Cognitive Impairment to Dementia.

Lan MJ, Ogden RT, Kumar D, Stern Y, Parsey RV, Pelton GH, Rubin-Falcone H, Pradhaban G, Zanderigo F, Miller JM, Mann JJ, Devanand DP.

J Alzheimers Dis. 2017;60(3):939-947. doi: 10.3233/JAD-161284.

17.

Prediction of Response to Antipsychotics in Patients with Dementia Remains a Conundrum.

Devanand DP.

Am J Geriatr Psychiatry. 2017 Jul;25(7):717-718. doi: 10.1016/j.jagp.2017.04.005. Epub 2017 Apr 11. No abstract available.

PMID:
28478996
18.

Association of Obstructive Sleep Apnea with Episodic Memory and Cerebral Microvascular Pathology: A Preliminary Study.

Kerner NA, Roose SP, Pelton GH, Ciarleglio A, Scodes J, Lentz C, Sneed JR, Devanand DP.

Am J Geriatr Psychiatry. 2017 Mar;25(3):316-325. doi: 10.1016/j.jagp.2016.11.009. Epub 2016 Nov 17.

19.

Prediction of Relapse After Discontinuation of Antipsychotic Treatment in Alzheimer's Disease: The Role of Hallucinations.

Patel AN, Lee S, Andrews HF, Pelton GH, Schultz SK, Sultzer DL, Mintzer J, de la Pena D, Gupta S, Colon S, Schimming C, Levin B, Devanand DP.

Am J Psychiatry. 2017 Apr 1;174(4):362-369. doi: 10.1176/appi.ajp.2016.16020226. Epub 2016 Nov 18.

20.

Clinical Trials to Gain FDA Approval for Computerized Cognitive Training: What Is the Ideal Control Condition?

Motter JN, Devanand DP, Doraiswamy PM, Sneed JR.

Front Aging Neurosci. 2016 Nov 2;8:249. eCollection 2016. No abstract available.

21.

Impact of Functional Deficits in Instrumental Activities of Daily Living in Mild Cognitive Impairment: A Clinical Algorithm to Predict Progression to Dementia.

Devanand DP, Liu X, Brown PJ.

Alzheimer Dis Assoc Disord. 2017 Jan-Mar;31(1):55-61. doi: 10.1097/WAD.0000000000000160.

22.

Low-dose Lithium Treatment for Agitation and Psychosis in Alzheimer Disease and Frontotemporal Dementia: A Case Series.

Devanand DP, Pelton GH, D'Antonio K, Strickler JG, Kreisl WC, Noble J, Marder K, Skomorowsky A, Huey ED.

Alzheimer Dis Assoc Disord. 2017 Jan-Mar;31(1):73-75. doi: 10.1097/WAD.0000000000000161. No abstract available.

23.

Brain Regions Involved in Arousal and Reward Processing are Associated with Apathy in Alzheimer's Disease and Frontotemporal Dementia.

Huey ED, Lee S, Cheran G, Grafman J, Devanand DP; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2017;55(2):551-558.

PMID:
27802220
24.

Olfactory Identification Deficits, Cognitive Decline, and Dementia in Older Adults.

Devanand DP.

Am J Geriatr Psychiatry. 2016 Dec;24(12):1151-1157. doi: 10.1016/j.jagp.2016.08.010. Epub 2016 Aug 17. Review.

25.

R- and S-citalopram concentrations have differential effects on neuropsychiatric scores in elders with dementia and agitation.

Ho T, Pollock BG, Mulsant BH, Schantz O, Devanand DP, Mintzer JE, Porsteinsson AP, Schneider LS, Weintraub D, Yesavage J, Drye LT, Munro CA, Shade DM, Lyketsos C, Bies R.

Br J Clin Pharmacol. 2016 Sep;82(3):784-92. doi: 10.1111/bcp.12997. Epub 2016 Jun 20.

26.

Principal components analysis of agitation outcomes in Alzheimer's disease.

Yesavage JA, Taylor JL, Friedman L, Rosenberg PB, Lazzeroni LC, Leoutsakos JS, Kinoshita LM, Perlow MJ, Munro CA, Devanand DP, Drye LT, Mintzer JE, Pollock BG, Porsteinsson AP, Schneider LS, Shade DM, Weintraub D, Lyketsos CG, Noda A; CitAD Research Group.

J Psychiatr Res. 2016 Aug;79:4-7. doi: 10.1016/j.jpsychires.2016.04.004. Epub 2016 Apr 16.

27.

Effects of Citalopram on Neuropsychiatric Symptoms in Alzheimer's Dementia: Evidence From the CitAD Study.

Leonpacher AK, Peters ME, Drye LT, Makino KM, Newell JA, Devanand DP, Frangakis C, Munro CA, Mintzer JE, Pollock BG, Rosenberg PB, Schneider LS, Shade DM, Weintraub D, Yesavage J, Lyketsos CG, Porsteinsson AP; CitAD Research Group.

Am J Psychiatry. 2016 May 1;173(5):473-80. doi: 10.1176/appi.ajp.2016.15020248. Epub 2016 Apr 1.

PMID:
27032628
28.

Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial.

Luchsinger JA, Perez T, Chang H, Mehta P, Steffener J, Pradabhan G, Ichise M, Manly J, Devanand DP, Bagiella E.

J Alzheimers Dis. 2016;51(2):501-14. doi: 10.3233/JAD-150493.

29.

Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer's Disease With Aggression or Agitation: The CitAD Randomized Clinical Trial.

Schneider LS, Frangakis C, Drye LT, Devanand DP, Marano CM, Mintzer J, Mulsant BH, Munro CA, Newell JA, Pawluczyk S, Pelton G, Pollock BG, Porsteinsson AP, Rabins PV, Rein L, Rosenberg PB, Shade D, Weintraub D, Yesavage J, Lyketsos CG; CitAD Research Group.

Am J Psychiatry. 2016 May 1;173(5):465-72. doi: 10.1176/appi.ajp.2015.15050648. Epub 2016 Jan 15.

30.

Sedation mediates part of Citalopram's effect on agitation in Alzheimer's disease.

Newell J, Yesavage JA, Taylor JL, Kraemer HC, Munro CA, Friedman L, Rosenberg PB, Madore M, Chao SZ, Devanand DP, Drye LT, Mintzer JE, Pollock BG, Porsteinsson AP, Schneider LS, Shade DM, Weintraub D, Lyketsos CG, Noda A; CitAD Research Group.

J Psychiatr Res. 2016 Mar;74:17-21. doi: 10.1016/j.jpsychires.2015.12.005. Epub 2015 Dec 12.

31.

Brain Regions Associated With Internalizing and Externalizing Psychiatric Symptoms in Patients With Penetrating Traumatic Brain Injury.

Huey ED, Lee S, Lieberman JA, Devanand DP, Brickman AM, Raymont V, Krueger F, Grafman J.

J Neuropsychiatry Clin Neurosci. 2016 Spring;28(2):104-11. doi: 10.1176/appi.neuropsych.15060150. Epub 2015 Dec 30.

32.

Characterization of brain mGluR5 binding in a pilot study of late-life major depressive disorder using positron emission tomography and [¹¹C]ABP688.

DeLorenzo C, Sovago J, Gardus J, Xu J, Yang J, Behrje R, Kumar JS, Devanand DP, Pelton GH, Mathis CA, Mason NS, Gomez-Mancilla B, Aizenstein H, Mann JJ, Parsey RV.

Transl Psychiatry. 2015 Dec 8;5:e693. doi: 10.1038/tp.2015.189.

33.

A population pharmacokinetic model for R- and S-citalopram and desmethylcitalopram in Alzheimer's disease patients with agitation.

Akil A, Bies RR, Pollock BG, Avramopoulos D, Devanand DP, Mintzer JE, Porsteinsson AP, Schneider LS, Weintraub D, Yesavage J, Shade DM, Lyketsos CG.

J Pharmacokinet Pharmacodyn. 2016 Feb;43(1):99-109. doi: 10.1007/s10928-015-9457-6. Epub 2015 Nov 26.

34.

Combined treatment with memantine/es-citalopram for older depressed patients with cognitive impairment: a pilot study.

Pelton GH, Harper OL, Roose SP, Marder K, D'Antonio K, Devanand DP.

Int J Geriatr Psychiatry. 2016 Jun;31(6):648-55. doi: 10.1002/gps.4375. Epub 2015 Nov 11.

PMID:
26559790
35.

Computerized Cognitive Training for Major Depressive Disorder: What's Next?

Motter JN, Devanand DP, Doraiswamy PM, Sneed JR.

Front Psychiatry. 2015 Oct 1;6:137. doi: 10.3389/fpsyt.2015.00137. eCollection 2015. Review. No abstract available.

36.

Computerized cognitive training and functional recovery in major depressive disorder: A meta-analysis.

Motter JN, Pimontel MA, Rindskopf D, Devanand DP, Doraiswamy PM, Sneed JR.

J Affect Disord. 2016 Jan 1;189:184-91. doi: 10.1016/j.jad.2015.09.022. Epub 2015 Sep 26. Review.

PMID:
26437233
37.

Olfactory Deficits Predict Cognitive Improvement on Donepezil in Patients With Depression and Cognitive Impairment: A Randomized Controlled Pilot Study.

Pelton GH, Soleimani L, Roose SP, Tabert MH, Devanand DP.

Alzheimer Dis Assoc Disord. 2016 Jan-Mar;30(1):67-9. doi: 10.1097/WAD.0000000000000107. No abstract available.

38.

Neuropsychiatric effects of neurodegeneration of the medial versus lateral ventral prefrontal cortex in humans.

Huey ED, Lee S, Brickman AM, Manoochehri M, Griffith E, Devanand DP, Stern Y, Grafman J.

Cortex. 2015 Dec;73:1-9. doi: 10.1016/j.cortex.2015.08.002. Epub 2015 Aug 15.

39.

Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trial.

Rosenberg PB, Drye LT, Porsteinsson AP, Pollock BG, Devanand DP, Frangakis C, Ismail Z, Marano C, Meinert CL, Mintzer JE, Munro CA, Pelton G, Rabins PV, Schneider LS, Shade DM, Weintraub D, Newell J, Yesavage J, Lyketsos CG; CitAD Research Group.

Int Psychogeriatr. 2015 Dec;27(12):2059-67. doi: 10.1017/S1041610215001106. Epub 2015 Aug 25.

40.

Citalopram for the Treatment of Agitation in Alzheimer Dementia: Genetic Influences.

Peters ME, Vaidya V, Drye LT, Devanand DP, Mintzer JE, Pollock BG, Porsteinsson AP, Rosenberg PB, Schneider LS, Shade DM, Weintraub D, Yesavage J, Lyketsos CG, Avramopoulos D; CitAD Research Group.

J Geriatr Psychiatry Neurol. 2016 Mar;29(2):59-64. doi: 10.1177/0891988715601735. Epub 2015 Aug 23.

41.

Time to Response to Citalopram Treatment for Agitation in Alzheimer Disease.

Weintraub D, Drye LT, Porsteinsson AP, Rosenberg PB, Pollock BG, Devanand DP, Frangakis C, Ismail Z, Marano C, Meinert CL, Mintzer JE, Munro CA, Pelton G, Rabins PV, Schneider LS, Shade DM, Yesavage J, Lyketsos CG; CitAD Research Group.

Am J Geriatr Psychiatry. 2015 Nov;23(11):1127-33. doi: 10.1016/j.jagp.2015.05.006. Epub 2015 May 19.

42.

Brain Amyloid Deposition and Longitudinal Cognitive Decline in Nondemented Older Subjects: Results from a Multi-Ethnic Population.

Gu Y, Razlighi QR, Zahodne LB, Janicki SC, Ichise M, Manly JJ, Devanand DP, Brickman AM, Schupf N, Mayeux R, Stern Y.

PLoS One. 2015 Jul 29;10(7):e0123743. doi: 10.1371/journal.pone.0123743. eCollection 2015.

43.

Olfactory identification deficits and increased mortality in the community.

Devanand DP, Lee S, Manly J, Andrews H, Schupf N, Masurkar A, Stern Y, Mayeux R, Doty RL.

Ann Neurol. 2015 Sep;78(3):401-11. doi: 10.1002/ana.24447. Epub 2015 Jul 3.

44.

Lithium treatment and risk for dementia in adults with bipolar disorder: population-based cohort study.

Gerhard T, Devanand DP, Huang C, Crystal S, Olfson M.

Br J Psychiatry. 2015 Jul;207(1):46-51. doi: 10.1192/bjp.bp.114.154047. Epub 2015 Jan 22.

PMID:
25614530
45.

Olfactory deficits predict cognitive decline and Alzheimer dementia in an urban community.

Devanand DP, Lee S, Manly J, Andrews H, Schupf N, Doty RL, Stern Y, Zahodne LB, Louis ED, Mayeux R.

Neurology. 2015 Jan 13;84(2):182-9. doi: 10.1212/WNL.0000000000001132. Epub 2014 Dec 3.

46.

Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition.

Cummings J, Mintzer J, Brodaty H, Sano M, Banerjee S, Devanand DP, Gauthier S, Howard R, Lanctôt K, Lyketsos CG, Peskind E, Porsteinsson AP, Reich E, Sampaio C, Steffens D, Wortmann M, Zhong K; International Psychogeriatric Association.

Int Psychogeriatr. 2015 Jan;27(1):7-17. doi: 10.1017/S1041610214001963. Epub 2014 Oct 14.

47.

An open treatment trial of duloxetine in elderly patients with dysthymic disorder.

Kerner N, D'Antonio K, Pelton GH, Salcedo E, Ferrar J, Roose SP, Devanand D.

SAGE Open Med. 2014 May 8;2. doi: 10.1177/2050312114533536.

48.

Whatever happened to new treatments for Alzheimer's disease?

Devanand DP.

J Clin Psychiatry. 2014 Jul;75(7):775-6. doi: 10.4088/JCP.14ac09246. Review. No abstract available.

PMID:
25093474
49.
50.

At the interface of sensory and motor dysfunctions and Alzheimer's disease.

Albers MW, Gilmore GC, Kaye J, Murphy C, Wingfield A, Bennett DA, Boxer AL, Buchman AS, Cruickshanks KJ, Devanand DP, Duffy CJ, Gall CM, Gates GA, Granholm AC, Hensch T, Holtzer R, Hyman BT, Lin FR, McKee AC, Morris JC, Petersen RC, Silbert LC, Struble RG, Trojanowski JQ, Verghese J, Wilson DA, Xu S, Zhang LI.

Alzheimers Dement. 2015 Jan;11(1):70-98. doi: 10.1016/j.jalz.2014.04.514. Epub 2014 Jul 9. Review.

Supplemental Content

Loading ...
Support Center